Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two - No Study Results Posted

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (CARE-MS II)

This study has been completed.

Study NCT00548405 Information provided by Genzyme

First Received: October 22, 2007 Last Updated: January 30, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)